1
|
Chaplin S. Latest audit shows the Diabetes Prevention Programme is pressing ahead in tackling non‐diabetic hyperglycaemia and type 2 risk. Practical Diabetes 2023. [DOI: 10.1002/pdi.2443] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2023]
|
2
|
Chaplin S. Key factors in the management of glycaemic control in people with cancer. Practical Diabetes 2022. [DOI: 10.1002/pdi.2406] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
3
|
Chaplin S. National audit of children and young people with type 2 diabetes shows rising trend in contributory factors of serious concern. Practical Diabetes 2022. [DOI: 10.1002/pdi.2399] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
4
|
Chaplin S. Paxlovid: antiviral combination for the treatment of
COVID
‐19. Prescriber 2022. [PMCID: PMC9111076 DOI: 10.1002/psb.1979] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
Paxlovid (nirmatrelvir/ritonavir) is an oral antiviral combination for the treatment of COVID‐19 in adults at risk of progression to severe disease. This article summarises its indications, interactions and efficacy.
Collapse
Affiliation(s)
- Steve Chaplin
- Steve Chaplin is a medical writer specialising in therapeutics
| |
Collapse
|
5
|
Khair K, Pollard D, Steadman L, Jenner K, Chaplin S. The views of women with bleeding disorders: Results from the Cinderella study. Haemophilia 2022; 28:316-325. [DOI: 10.1111/hae.14514] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2021] [Revised: 01/06/2022] [Accepted: 02/04/2022] [Indexed: 12/29/2022]
|
6
|
Sanigorska A, Chaplin S, Holland M, Khair K, Pollard D. The lived experience of women with a bleeding disorder: A systematic review. Res Pract Thromb Haemost 2022; 6:e12652. [PMID: 35141459 PMCID: PMC8813663 DOI: 10.1002/rth2.12652] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2021] [Revised: 11/14/2021] [Accepted: 12/09/2021] [Indexed: 01/30/2023] Open
Abstract
Background Research studies have described the morbidity associated with inherited bleeding disorders such as hemophilia and von Willebrand disease in women, but their effect on daily living has long been underrecognized. This systematic review sought to document the lived experience of women with a bleeding disorder by assessing research findings on quality of health care, socioeconomic factors, and mental health. Methods A systematic search was carried out in Web of Science, the Cumulative Index to Nursing and Allied Health Literature, and PubMed on July 31, 2020. References were hand searched. Abstracts of the 2019 and 2020 congresses on bleeding disorders were hand searched. Key journals were screened for relevant studies published after the search date until the analysis was completed on December 7, 2020. Results Of 635 potentially eligible publications, 27 published since 1998 were selected for review. Most studies were of moderate to high quality but meta‐analysis of quantitative studies was not possible due to difference in outcomes and assessment. Women with a bleeding disorder experience obstacles to accessing care, difficulties living with their disorder, interference with schooling and work, and poor mental health. Diagnostic delay and lack of recognition of symptoms mean treatment and support may not be available. Where comparisons with controls were made, women’s negative experiences were greater than those of men. Conclusions Women with bleeding disorders experience major negative impacts of their disorders on daily life and mental well‐being. Many of the challenges identified in earlier research are evident in more recent studies.
Collapse
Affiliation(s)
- Anna Sanigorska
- Oxford Haemophilia and Thrombosis Centre Churchill Hospital Oxford UK
| | | | | | | | - Debra Pollard
- Haemnet London UK
- Katharine Dormandy Haemophilia Centre Royal Free Hospital London UK
| |
Collapse
|
7
|
Chaplin S. Biosimilar insulins: will switching soon be the norm? Pract Diab 2021. [DOI: 10.1002/pdi.2346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
8
|
Abstract
NICE, SIGN and the Royal College of General Practitioners have published a joint guideline on identifying and managing the long‐term effects of COVID‐19 (‘long COVID’) in adults, young people and children. This article summarises the main points of the guidance.
Collapse
Affiliation(s)
- Steve Chaplin
- Steve Chaplin is a freelance medical writer specialising in therapeutics
| |
Collapse
|
9
|
Fletcher S, Jenner K, Holland M, Chaplin S, Khair K. An exploration of why men with severe haemophilia might not want gene therapy: The exigency study. Haemophilia 2021; 27:760-768. [PMID: 34265145 DOI: 10.1111/hae.14378] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2021] [Revised: 06/15/2021] [Accepted: 07/05/2021] [Indexed: 11/27/2022]
Abstract
INTRODUCTION For many people with haemophilia (PwH) gene therapy offers a potential functional cure. However, some have stated that they do not wish to have gene therapy either now or in the future. AIM This sub-study, part of the larger Exigency programme, assesses the attitudes, views and understanding of those who do not wish to undergo gene therapy. METHODS Participants were approached via social media and word of mouth referral and invited to participate in a focus group or individual interview to discuss their views. Interviews were recorded, transcribed verbatim and analysed thematically. RESULTS Ten adult men with severe haemophilia (eight haemophilia A and two haemophilia B), mean age 34.3 years, participated in a 1-h focus group (n = 9) or interview (n = 1). All were on prophylaxis. None reported significant treatment burden, and all had annual bleeding rates of less than five in the previous 12 months. Four major themes emerged: self-identity and its loss, lack of long-term safety and efficacy data, ongoing concerns about past viral infection, and lack of current treatment burden. CONCLUSION There are many concerns about gene therapy, including eligibility, effectiveness and safety, which may result in individuals declining it as a therapy. These concerns may recede as more data are published. This study reveals a psychological dynamic around self-identity and belonging for PwH. The nature of this dynamic is poorly understood and needs exploration to facilitate support for those making decisions about gene therapy.
Collapse
Affiliation(s)
- Simon Fletcher
- Oxford Haemophilia and Thrombosis Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
| | | | | | | | | |
Collapse
|
10
|
Khair K, Steadman L, Chaplin S, Holland M, Jenner K, Fletcher S. Parental perspectives on gene therapy for children with haemophilia: The Exigency study. Haemophilia 2020; 27:120-128. [PMID: 33216422 DOI: 10.1111/hae.14188] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2020] [Revised: 10/15/2020] [Accepted: 10/15/2020] [Indexed: 12/24/2022]
Abstract
INTRODUCTION Gene therapy is used in life-limiting conditions of childhood. While not a current therapeutic option for children with haemophilia, it may be considered in the future especially for those where access to treatment is limited. AIM To assess the attitudes and opinions of parents of children with haemophilia about gene therapy as a potential future treatment, by understanding their awareness about gene therapy and what they need to know now and in the future; gauging levels of interest in gene therapy for their children; and exploring perceived current motivations and barriers. METHODS A mixed methods study with an online questionnaire and in-depth qualitative interviews in focus groups which were analysed using thematic analysis. RESULTS One hundred and fifty-eight participants commenced the online survey; 63 were fully completed (39%). 60 had heard of gene therapy but few (17/60 [28.3%]) felt they had a good understanding. 38/60 (63.3%) respondents did not know that gene therapy is not available for children. However, most held positive views: 53/60 (88.3%) saying they would consider it for their child. In the interviews, participants (N = 10, all mothers) discussed their awareness and understanding of gene therapy and opinions about it for children, including how this should be communicated to the child and parents. CONCLUSION A coherent, community-wide strategy for communicating information and news about gene therapy should now be provided for children and families living with haemophilia. This should come primarily from trusted haemophilia nursing teams, who can give tailored, age-appropriate, factual advice.
Collapse
Affiliation(s)
| | | | | | | | | | - Simon Fletcher
- Oxford Haemophilia and Thrombosis Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
| |
Collapse
|
11
|
O'Hara S, Castro FA, Black J, Chaplin S, Ruiz L, Hampton RJ, Sima CS, O'Hara J. Disease burden and remaining unmet need in patients with haemophilia A treated with primary prophylaxis. Haemophilia 2020; 27:113-119. [PMID: 33084176 DOI: 10.1111/hae.14171] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2019] [Revised: 09/14/2020] [Accepted: 09/21/2020] [Indexed: 01/01/2023]
Abstract
AIMS There is evidence that people with haemophilia A still experience morbidity and functional limitation due to joint damage despite prophylaxis. This study aimed to compare their quality of life and work-related function with that of the general population and patients with osteoarthritis. METHODS Data from the Cost of Haemophilia in Europe: a Socioeconomic Survey (CHESS) database were compared with published data from normative populations and patients with osteoarthritis in Europe and the United States. RESULTS In the predominantly young (age 18-35 years) adult CHESS population treated with primary prophylaxis, about 30% reported a target joint; the average frequency of bleeds was one per year; half reported chronic pain. Levels of anxiety and depression were similar to those reported by people using on-demand treatment. Employment and productivity were lower than in the general population. The level of presenteeism (attending work with impairment) was comparable with that reported for a much older population with osteoarthritis who had more extensive joint damage and greater prevalence of pain. CONCLUSION Compared with the general population, clinical outcomes and quality of life are indicated to be impaired for young adults whose haemophilia is managed by primary prophylaxis. Primary prophylaxis is not associated with lower levels of anxiety and depression than on-demand treatment, and pain is common. The level of presenteeism is comparable to that reported in people with osteoarthritis, an older population with more joint disease. Further studies are needed to fully assess the implications of compromised work performance among young adults with haemophilia as they seek to build a career.
Collapse
Affiliation(s)
| | - Felipe A Castro
- PHC Data Science, F. Hoffmann-La Roche Ltd., Basel, Switzerland
| | - James Black
- PHC Data Science, F. Hoffmann-La Roche Ltd., Basel, Switzerland
| | | | | | - Roger J Hampton
- PHC Data Science, F. Hoffmann-La Roche Ltd., Basel, Switzerland
| | - Camelia S Sima
- PHC Data Science, F. Hoffmann-La Roche Ltd., South San Francisco, CA, USA
| | | |
Collapse
|
12
|
Chaplin S. ‘Diabetes at the front door’: meeting the needs of diabetes patients in emergency. Pract Diab 2020. [DOI: 10.1002/pdi.2279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
13
|
Abstract
Coronavirus disease (COVID‐19) is now dominating the lives of everyone, and its history is constantly being rewritten. This article gives a brief account of the story so far: where SARS‐CoV‐2 might have originated, how it compares with other viruses that cause major respiratory disease, and some of the treatments and vaccines currently being investigated to combat it.
Collapse
Affiliation(s)
- Steve Chaplin
- Steve Chaplin is a freelance medical writer specialising in therapeutics
| |
Collapse
|
14
|
Chaplin S. Latest findings from the National Pregnancy in Diabetes audit give cause for concern. Pract Diab 2020. [DOI: 10.1002/pdi.2266] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
15
|
|
16
|
Chaplin S. ESC/EASD guideline sheds light on diabetes and cardiovascular disease management. Pract Diab 2020. [DOI: 10.1002/pdi.2256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
17
|
|
18
|
|
19
|
Chaplin S. Antibodies against CGRP for prevention of migraine. Prog Neurol Psychiatry 2019. [DOI: 10.1002/pnp.536] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
20
|
|
21
|
|
22
|
|
23
|
|
24
|
|
25
|
Chaplin S. Primary care diabetes prescribing volume and costs are on the increase. Pract Diab 2017. [DOI: 10.1002/pdi.2144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
26
|
Chaplin S. The latest National Diabetes Audit report sheds light on complications and mortality rates. Pract Diab 2017. [DOI: 10.1002/pdi.2138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
27
|
Chaplin S. The impact of transition on NHS diabetes service delivery: key audit results spanning 2003-2014. Pract Diab 2017. [DOI: 10.1002/pdi.2131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
28
|
|
29
|
|
30
|
|
31
|
|
32
|
Chaplin S. Praise and brickbats: the latest results of National Diabetes Audits for England and Wales. Pract Diab 2017. [DOI: 10.1002/pdi.2103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
33
|
Chaplin S. Management of diabetic neuropathy: the ADA's latest statement fleshes out NICE guidance. Pract Diab 2017. [DOI: 10.1002/pdi.2093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
34
|
|
35
|
|
36
|
|
37
|
|
38
|
|
39
|
|
40
|
Chaplin S. NICE quality standards: driving improved care? Pract Diab 2016. [DOI: 10.1002/pdi.2058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
41
|
|
42
|
|
43
|
|
44
|
|
45
|
|
46
|
|
47
|
Chaplin S. Insulin pump risks and benefits: an analysis of the EASD/ADA joint statement. Pract Diab 2016. [DOI: 10.1002/pdi.2010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
48
|
|
49
|
|
50
|
|